comprehensive -WSS

comprehensive

author：leisure time 2025-09-29 22:46:56 - browse：82316

ASH19 CAR-T — Victor Segura Ibarra and Rita Serda, Ph.D., NCI, NIH

The Food and Drug Administration on Wednesday approved a futuristic new approach to treating cancer, clearing a Novartis therapy that has produced unprecedented results in patients with a rare and deadly cancer. The price tag: $475,000 for a course of treatment.

That sounds staggering to many patients — but it’s far less than analysts expected.

The therapy, called a CAR-T, is made by harvesting patients’ white blood cells and rewiring them to home in on tumors. Novartis’s product is the first CAR-T therapy to come before the FDA, leading a pack of novel treatments that promise to change the standard of care for certain aggressive blood cancers.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： Change Healthcare cyberattack prompts Medicare loan program

WSS

A deep dive into Applied Therapeutics’ data, and questions on Cassava

Headspace, Meta partner to launch VR meditation app for Quest

How medical schools plan to diversify without affirmative action

Hospitals consider fixing cancer drug shortages on their own

Air quality improving but still lags in Black, Hispanic communities

Amylyx ALS drug failure raises questions and concerns

focus

comprehensive

focus

Duchenne breakthrough therapy leaves behind pioneering families

Amylyx ALS drug fails large clinical trial

Wildfire smoke exposes gaps in outdoor worker protections

With psoriasis trial ahead, Alumis raises $259 million

Food as medicine: CMS rules hamper 'prescribing' of fruits, veggies

How medical schools plan to diversify without affirmative action

The Supreme Court will review a ruling striking down a domestic violence federal gun ban

What to make of Biden’s latest efforts on cancer research

Walensky prepares to leave CDC — and Congress — behind

Amylyx ALS drug failure raises questions and concerns

entertainment

Popular nasal decongestant doesn't actually relieve congestion

Walmart eyes Medicare Advantage provider ChenMed

RSV shot was 90% effective at preventing hospitalizations in kids

New Covid vaccine is recommended for everyone 6 months or older

NEJM study link tiny plastics in blood vessels to heart problems

Change Healthcare payments predicted restored March 15

explore

explore

focus

hotspot